Authorized purpose: Process previously acquired DICOM-compliant cardiac ultrasound images and make automated cardiac measurements to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in adult clinical decision-making.
Clinical role
Post-acquisition image eligibility and quality control followed by automated measurement support; the reviewing clinician can accept, reject, edit, or ignore the output and review the generated report.
Images and patients
Ultrasound · Heart and cardiovascular structures
Key limitation
Keep in mind: Indicated for adults and qualified clinical users. The output supports review and clinical decision-making and remains subject to clinician confirmation; it is not an independent diagnostic decision. The FDA standalone study used one selected DICOM view per case from GE and Teratech systems, so broader protocol or vendor performance is not established by this packet.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Process previously acquired DICOM-compliant cardiac ultrasound images and make automated cardiac measurements to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in adult clinical decision-making.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart and cardiovascular structures Input: Previously acquired DICOM-compliant transthoracic cardiac ultrasound images, including appropriate PLAX, A2C, or A4C views with acceptable quality and identifiable end-diastolic and end-systolic frames.
Who uses it?Intended users: Qualified cardiologists, sonographers, accredited echocardiographers, or other licensed professional healthcare practitioners.
What does the software produce?Output: Automated measurements of left-ventricular volume and diameter, right-ventricular diameter, posterior-wall thickness, aortic annulus, LV outflow tract, sinus of Valsalva, sinotubular junction, left-atrium dimension, and interventricular septal thickness; results are viewable in a browser interface, report, or PDF and are intended for third-party software or hardware consumption.
What is its most important limitation?Key limitation: Indicated for adults and qualified clinical users. The output supports review and clinical decision-making and remains subject to clinician confirmation; it is not an independent diagnostic decision. The FDA standalone study used one selected DICOM view per case from GE and Teratech systems, so broader protocol or vendor performance is not established by this packet.
Clinical takeaway. Clinical role: Process previously acquired DICOM-compliant cardiac ultrasound images and make automated cardiac measurements to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in adult clinical decision-making.
Evidence takeaway. Evidence from the reviewed source record: FDA retrospective standalone performance testing used 200 distinct patients from two independent U.S. clinical sites, with one selected DICOM view per case. Ground truth was the mean of three experienced U.S. cardiac sonographers. The study evaluated the bivariate linear regression coefficient slope (BLRSC) against the reference annotations; all predefined limits were met, with listed BLRSC point estimates ranging from 0.773 to 1.112. The FDA summary also describes median absolute error, median percent error, Pearson and Spearman correlation, and Individual Equivalence Coefficient analyses, but does not report sensitivity or specificity. No data from the sites were used for training or tuning.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Process previously acquired DICOM-compliant cardiac ultrasound images and make automated cardiac measurements to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in adult clinical decision-making.
Post-acquisition image eligibility and quality control followed by automated measurement support; the reviewing clinician can accept, reject, edit, or ignore the output and review the generated report.
Previously acquired DICOM-compliant transthoracic cardiac ultrasound images, including appropriate PLAX, A2C, or A4C views with acceptable quality and identifiable end-diastolic and end-systolic frames.
Automated measurements of left-ventricular volume and diameter, right-ventricular diameter, posterior-wall thickness, aortic annulus, LV outflow tract, sinus of Valsalva, sinotubular junction, left-atrium dimension, and interventricular septal thickness; results are viewable in a browser interface, report, or PDF and are intended for third-party software or hardware consumption.
Adult clinical echocardiography workflow; the FDA packet permits secure cloud-server or on-premise-server deployment but does not name a specific facility type.
Indicated for adults and qualified clinical users. The output supports review and clinical decision-making and remains subject to clinician confirmation; it is not an independent diagnostic decision. The FDA standalone study used one selected DICOM view per case from GE and Teratech systems, so broader protocol or vendor performance is not established by this packet.
FDA retrospective standalone performance testing used 200 distinct patients from two independent U.S. clinical sites, with one selected DICOM view per case. Ground truth was the mean of three experienced U.S. cardiac sonographers. The study evaluated the bivariate linear regression coefficient slope (BLRSC) against the reference annotations; all predefined limits were met, with listed BLRSC point estimates ranging from 0.773 to 1.112. The FDA summary also describes median absolute error, median percent error, Pearson and Spearman correlation, and Individual Equivalence Coefficient analyses, but does not report sensitivity or specificity. No data from the sites were used for training or tuning.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA retrospective standalone performance testing used 200 distinct patients from two independent U.S. clinical sites, with one selected DICOM view per case. Ground truth was the mean of three experienced U.S. cardiac sonographers. The study evaluated the bivariate linear regression coefficient slope (BLRSC) against the reference annotations; all predefined limits were met, with listed BLRSC point estimates ranging from 0.773 to 1.112. The FDA summary also describes median absolute error, median percent error, Pearson and Spearman correlation, and Individual Equivalence Coefficient analyses, but does not report sensitivity or specificity. No data from the sites were used for training or tuning.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
EchoMeasure regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K241430
Samplen=200
IndependenceIndependence not established
K241430
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K241430. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Previously acquired DICOM-compliant transthoracic cardiac ultrasound images, including appropriate PLAX, A2C, or A4C views with acceptable quality and identifiable end-diastolic and end-systolic frames.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Receives DICOM inputs and can be deployed on a secure cloud server or on-premise server; output can be consumed by third-party software or hardware, viewed in a native browser interface, and downloaded as PDF. Specific PACS, RIS, EHR, interface versions, and local compatibility are not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes software that can be deployed on a cloud server or on-premise server, with a native browser interface for reviewing the report summary. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "the iCardio.ai EchoMeasure software works with digital imaging and communications in medicine (DICOM) echocardiography images and can be deployed on a secure cloud server or on-premise server." … "Additionally iCardio.ai has a native browser interface for reviewing the report summary as well as a functionality to download the available report in PDF format.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Automated measurements of left-ventricular volume and diameter, right-ventricular diameter, posterior-wall thickness, aortic annulus, LV outflow tract, sinus of Valsalva, sinotubular junction, left-atrium dimension, and interventricular septal thickness; results are viewable in a browser interface, report, or PDF and are intended for third-party software or hardware consumption.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Automated measurements of left-ventricular volume and diameter, right-ventricular diameter, posterior-wall thickness, aortic annulus, LV outflow tract, sinus of Valsalva, sinotubular junction, left-atrium dimension, and interventricular septal thickness; results are viewable in a browser interface, report, or PDF and are intended for third-party software or hardware consumption.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes software that can be deployed on a cloud server or on-premise server, with a native browser interface for reviewing the report summary. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "the iCardio.ai EchoMeasure software works with digital imaging and communications in medicine (DICOM) echocardiography images and can be deployed on a secure cloud server or on-premise server." … "Additionally iCardio.ai has a native browser interface for reviewing the report summary as well as a functionality to download the available report in PDF format.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Receives DICOM inputs and can be deployed on a secure cloud server or on-premise server; output can be consumed by third-party software or hardware, viewed in a native browser interface, and downloaded as PDF. Specific PACS, RIS, EHR, interface versions, and local compatibility are not established.
ACR AI Central provides an exact-submission model card for EchoMeasure; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K241430 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.
Authorized purpose: Provides AI-assisted cardiac, lung and abdominal quality feedback and measurements; users remain responsible for scan quality and diagnosis and must not rely solely on the software.
Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.